Moderna says the FDA will consider its new flu shot after resolving a public dispute
#Moderna #FDA #flu vaccine #approval #dispute #first-of-its-kind #medical regulation
📌 Key Takeaways
- FDA plans to consider approval of Moderna's new flu vaccine.
- The consideration follows resolution of a dispute that previously blocked the application.
- The vaccine is Moderna's first-of-its-kind flu shot.
📖 Full Retelling
The U.S. Food and Drug Administration (FDA) announced it will consider approving Moderna's new flu vaccine, after resolving a dispute that had previously blocked the company's application for its first-of-its-kind shot.
🏷️ Themes
Medical regulation, Vaccination development, Health policy, Innovation in vaccines
Entity Intersection Graph
No entity connections available yet for this article.
Original Source
The Food and Drug Administration will consider whether to approve Moderna's new flu vaccine after all, resolving a dispute that had blocked the company's application for the first-of-its-kind shot.
Read full article at source